MA

Mohammed Abdul Waseem

Director Director DIN 06822951
DIN 06822951 First appointment Mar 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2014
Shareholding value Locked Premium profile

About Mohammed Abdul Waseem

Mohammed Abdul Waseem has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06822951
Primary Designation Director
First Appointment 31 Mar 2014
Oldest Company Age 12 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Renfred Pharma Private Limited U24232AS2014PTC011855
Director 31 Mar 2014 2014 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Renfred Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammed Abdul Waseem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Abdul Waseem

Mohammed Abdul Waseem has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Mohammed Abdul Waseem is associated with 0 companies as Director.

Mohammed Abdul Waseem has expertise in General Business.

Mohammed Abdul Waseem has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available